drugset / Trial / NCT00478322

Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects

NCT00478322 ↗

Phase 2 Completed 24 enrolled Incyte Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

Purpose: A 28-day US study in patients with type 2 diabetes mellitus to assess the safety and tolerability as well as the effects of treatment with an investigational drug.

Timeline

Start
2007-04
Primary completion
2007-11
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject INCB013739 Unknown 100 mg —